Multiple sclerosis and HIV-1 infection: case report of a HIV controller

Journal of NeuroVirology

Volumn 21, Issue 4, 2015, Pages 464-467

  Chin, Jerome H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretroviral; HIV; Multiple sclerosis; Transverse myelitis

Indexed keywords

ANALGESIC AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ARTEMETHER PLUS BENFLUMETOL; CONTRAST MEDIUM; COTRIMOXAZOLE; GLUCOSE; HEMOGLOBIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; QUININE; SODIUM; VIRUS RNA;

ACUTE DISEASE; ADULT; ANALGESIA; ANTIVIRAL THERAPY; ARM WEAKNESS; ARTICLE; BABINSKI REFLEX; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHEEK; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIZZINESS; ERYTHROCYTE COUNT; EYE BURN; EYE PAIN; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIV RAPID TEST; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERREFLEXIA; INFECTION CONTROL; LEUKOCYTE COUNT; LIMB WEAKNESS; MONOCULAR VISION; MOUTH PAIN; MULTIPLE SCLEROSIS; MYELITIS; NAUSEA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PLASMODIUM; PRIORITY JOURNAL; RELAPSE; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; TRIGEMINUS NEURALGIA; UGANDA; UGANDAN; VIRUS LOAD; VISUAL FIELD; VOMITING; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84938419015     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-015-0335-1     Document Type: Article

References (15)

1. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M (1989) Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 39:324–329
2. Chakrabarti L, Simon V (2010) Immune mechanisms of HIV control. Curr Opin Immunol 22:488–496
3. Chalkley J, Berger JR (2014) Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol 20:640–643
4. Delgado SR, Maldonado J, Rammohan KW (2014) CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review. J Neurovirol 20:531–537
5. Feyissa AM, Singh P, Smith RG (2013) Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections. Mult Scler 19:1363–1366
6. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:1–11
7. Gaardbo JC, Hartling HJ, Gerstoft J, Nielsen SD (2012) Thirty years with HIV infection—nonprogression is still puzzling: lessons to be learned from controllers and long-term nonprogressors. AIDS Res Treat. doi:10.1155/2012/161584
8. Gold J, Goldacre R, Maruszak H, Giovannoni G, Yeates D, Goldacre M (2015) HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry 86:9–12
9. González-Duarte A, Ramirez C, Pinales R, Sierra-Madero J (2011) Multiple sclerosis typical clinical and MRI findings in a patient with HIV infection. J Neurovirol 17:504–508
10. Maruszak H, Brew BJ, Giovannoni G, Gold J (2011) Could antiretroviral drugs be effective in multiple sclerosis? A case report. Eur J Neurol 18:e110–e111
11. Multiple Sclerosis International Federation (2013) Atlas of MS 2013. Available via http://www.msif.org/about-us/advocacy/atlas-test/atlas-of-ms/. Accessed 12 February 2015
12. Nissen KK, Laska MJ, Hansen B, Terkelsen T, Villesen P, Bahrami S, Petersen T, Pedersen FS, Nexø BA (2013) Endogenous retroviruses and multiple sclerosis—new pieces to the puzzle. BMC Neurol 13:111. doi:10.1186/1471-2377-13-111
13. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
14. Poropatich K, Sullivan DR (2011) Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol 92:247–268
15. Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, Nakashima I, Apostolos-Pereira SL, Talim N, Simm RF, Lino AMM, Misu T, Leite MI, Aoki M, Fujihara K (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474–481